Company intelligence / Profile preview

Pivotal bioVenture Partners China

Shanghai, China

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Pivotal bioVenture Partners China is a leading strategic venture capital firm focusing on investing in private innovative therapeutics, medical devices, and healthcare services companies, with emphasis on unmet needs in Greater China. It is a member of Nan Fung Life Sciences and operates as the China arm of Pivotal Life Sciences, leveraging deep industry experience to build and support new ventures addressing major healthcare gaps.[1][3][4][5]

Industry: Investors

Partnerships

Frazier Healthcare Partners (Formed SanReno Therapeutics, a JV for kidney disease therapies in Greater China and Singapore)

Beyond the preview

Go deeper on Pivotal bioVenture Partners China.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pivotal bioVenture Partners China.

Explore the full profile